ロード中...
Sarilumab for recalcitrant Cystoid Macular Edema in non-paraneoplastic Autoimmune Retinopathy
PURPOSE: To demonstrate rapid improvement of recalcitrant cystoid macular edema (CME) and perivascular leakage, in a patient with non-paraneoplastic autoimmune retinopathy (npAIR) and autoimmune optic neuropathy (AON) after treatment with sarilumab, a human anti-interleukin-6 (IL-6) receptor antibod...
保存先:
| 出版年: | Retin Cases Brief Rep |
|---|---|
| 主要な著者: | , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
2021
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6783341/ https://ncbi.nlm.nih.gov/pubmed/30986811 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/ICB.0000000000000872 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|